Home Healthcare Healthcare Services Oligonucleotide CDMO Market

Oligonucleotide CDMO Market Size, Share & Trends Analysis Report By Service Type (Contract Manufacturing, Contract Development), By Type (Antisense Oligonucleotides, Small Interfering RNA, Other Oligonucleotides), By Application (Therapeutic, Research, Diagnostic), By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostic Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
  7. North America Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
  8. Europe Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    8. France
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
  9. APAC Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
    6. China
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    9. India
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
  10. Middle East and Africa Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
  11. LATAM Oligonucleotide CDMO Market Size Analysis
    1. Introduction
    2. Oligonucleotide CDMO Market Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
      1. Contract Manufacturing
      2. Contract Development
    3. Oligonucleotide CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Antisense Oligonucleotides
      2. Small Interfering RNA
      3. Other Oligonucleotides
    4. Oligonucleotide CDMO Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Therapeutic
      2. Research
      3. Diagnostic
    5. Oligonucleotide CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical and Biopharmaceutical Companies
      2. Diagnostic Companies
      3. Others
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Service Type 2022-2034 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. Contract Development
      3. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Antisense Oligonucleotides
        2. Small Interfering RNA
        3. Other Oligonucleotides
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutic
        2. Research
        3. Diagnostic
      5. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Diagnostic Companies
        3. Others
  12. Competitive Landscape
    1. Oligonucleotide CDMO Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. PolyPeptide Group
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. STA Pharmaceutical Co. Ltd.
    3. Bachem
    4. Creative Peptides
    5. Aurigene Pharmaceutical Services Ltd.
    6. Merck KGaA
    7. EUROAPI
    8. Curia Global, Inc.
    9. CordenPharm
    10. Sylentis, S.A.
    11. Thermo Fisher Scientific Inc.
    12. Agilent Technologies, Inc.
    13. Lonza
    14. PolyPeptide Group
    15. Creative Biogene
    16. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.